# A Single Dose-escalation Study of Cytisine in Adult Smokers

> **NCT03848208** · PHASE1 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 74 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** cytisine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03848208
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-28
- **Primary completion:** 2019-09-12
- **Final completion:** 2019-09-12
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03848208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03848208, "A Single Dose-escalation Study of Cytisine in Adult Smokers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03848208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*